News | Cardiac Imaging | September 09, 2019

Panel of 26 experts from nine professional cardiology societies release new document to facilitate earlier diagnosis, improved disease management

ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus

September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along with eight other societies on recommendations for multimodality imaging in cardiac amyloidosis in the Journal of Nuclear Cardiology.  ASNC assembled a writing team of 26 experts in cardiovascular imaging and amyloidosis representing these nine societies: the American College of Cardiology (ACC), the American Heart Association (AHA), the American Society of Echocardiography (ASE), the European Association of Nuclear Medicine (EANM), the Heart Failure Society of America (HFSA), the International Society of Amyloidosis (ISA), the Society of Cardiovascular Magnetic Resonance (SCMR), and the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Emerging imaging methods have facilitated earlier diagnosis of cardiac amyloidosis and improved prognostication and management with new treatment options. The diagnostic criteria for cardiac amyloidosis, required updating to include these novel imaging tools.

Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality characterized by the deposition of amyloid fibrils (misfolded protein deposits) into myocardial tissue. An ideal non-invasive diagnostic method would identify cardiac involvement in amyloidosis and would also confirm the etiologic subtype. No existing diagnostic tools can provide this information individually, necessitating a multimodality cardiac imaging approach.

The purpose of the new consensus document is to: 

  1. Achieve multisocietal consensus on standardized imaging methods, image acquisition, interpretation and reporting; 

  2. Develop multisocietal consensus criteria for the diagnosis of cardiac amyloidosis combining histopathology, laboratory and imaging features; and 

  3. Define appropriate use of imaging in cardiac amyloidosis. 

The writing group reviewed and summarized available literature for imaging in cardiac amyloidosis, and provided comprehensive expert recommendations regarding the role of imaging in cardiac amyloidosis based on evidence combined with expert opinion.

The joint expert consensus document on imaging cardiac amyloidosis is divided into two parts:

"For the first time, imaging experts conferred with heart failure experts and amyloidosis experts to provide guidance on standardized imaging techniques, diagnostic criteria and appropriate utilization of echocardiography, cardiac magnetic resonance imaging and radionuclide imaging in cardiac amyloidosis. We anticipate that these expert multisocietal consensus recommendations on multimodality imaging in cardiac amyloidosis will standardize the diagnosis and improve the management of this highly morbid and underdiagnosed disease." stated writing chairs, Sharmila Dorbala, M.D., MPH, FASNC, director of nuclear cardiology, Brigham and Women's Hospital; and Jamieson Bourque, M.D., MHS, FASNC, director of nuclear cardiology at the University of Virginia.

Watch a video interview with Dorbala about the new guidelines. 

The experts in the writing group envision the use of these consensus recommendations will improve the clinical care and outcomes of individuals affected by cardiac amyloidosis, particularly with newly approved treatments now available. The literature gaps identified could spur relevant research to broaden the understanding of this complex disease and support future development of imaging guidelines for cardiac amyloidosis.

For more information:


1. Dorbala S., Ando Y., Bokhari S., et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. Journal of Nuclear Cardiology, published online Aug. 29, 2019.

2. Dorbala S., Ando Y., Bokhari S., et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization. Journal of Nuclear Cardiology, published online Aug. 29, 2019.

Related Content

News | Magnetic Resonance Imaging (MRI)

November 24, 2021 — Royal Philips announced new AI-enabled innovations in MR imaging launching at the Radiological ...

Time November 24, 2021
News | Magnetic Resonance Imaging (MRI)

November 23, 2021 — Researchers at Yale University analyzing specialized MRI exams found significant changes in the ...

Time November 23, 2021
News | Nuclear Imaging

November 22, 2021 — IBA, a leader in particle accelerator technology, and NorthStar Medical Radioisotopes LLC, a global ...

Time November 22, 2021
News | Magnetic Resonance Imaging (MRI)

November 22, 2021 — Adolescents and young adults with post-concussive symptoms who suffered three to five concussions ...

Time November 22, 2021
News | X-Ray

November 19, 2021 — Carestream Health will showcase its innovations in mobile medical imaging with the Ziehm Vision RFD ...

Time November 19, 2021
News | Artificial Intelligence

November 18, 2021 —, a leader in AI-driven intelligent care coordination, announced the U.S. commercial launch of ...

Time November 18, 2021
News | Magnetic Resonance Imaging (MRI)

November 17, 2021 — The University of Michigan Health System recently became the first U.S. healthcare institution to ...

Time November 17, 2021
News | Digital Pathology

November 15, 2021 — Saltus Biotech, a leader in 8k image technology, introduces a new high-end computer workstation and ...

Time November 15, 2021
Videos | Radiation Therapy

Siemens and Philips demonstrated examples of new imaging software to convert MRI datasets into synthetic computed ...

Time November 15, 2021
News | Radiology Imaging

Noveember 11, 2021 — Siemens Healthineers and UC San Francisco have formed a research and innovation-driven ...

Time November 11, 2021
Subscribe Now